<DOC>
	<DOC>NCT00000336</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging, MRI) post-hoc as a possible variable for future stratification in clinical trials.</brief_summary>
	<brief_title>Selegiline in Outpatient Treatment for Cocaine Dependence - 1</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>M/F ages 2150. Meets DSMIV criteria for cocaine. Agreeable to conditions of study and signed informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 1996</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>